Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 220 results found. Search for [ pharmaceutical manufacturers ]

Results 80 to 100 of 220
E Kumar Sharma
New Delhi, October 24, 2017
On October 20th the ministry of chemicals and fertilizers issued a press note in what seems an attempt to allay industry fears on the issue of price controls.


Akshat Khandelwal
New Delhi, October 7, 2017
RUTF is a medical food and not a supplement designed to replace any supplementary, locally -based feeding practices - nor does it discourage in any form natural practices such as breast-feeding.


Joe C Mathew
New Delhi, August 31, 2017
The Medical Technology Association of India (MTaI), a representative body of the domestic arm of global medical device makers, has asked the drug price regulator National Pharmaceutical Pricing Authority (NPPA) to review its decision to cap the prices of knee implants.


E Kumar Sharma
New Delhi, August 28, 2017
The most striking thing about the policy draft is, that it has good policy goals but gives little thought on the road map and challenges in meeting them.


Joe C Mathew
New Delhi, August 21, 2017
The draft pharmaceutical policy 2017, floated by the ministry of chemicals and fertilizers for stakeholder opinion recently, has rightly diagnosed the problems that are plaguing Indian drug industry.


Reuters
New Delhi, August 17, 2017
With India-China relations going through a tough phase, efforts to curb Chinese business has gathered more support from within the administration.


Joe C Mathew
New Delhi, August 17, 2017
NPPA stated that the decision was taken after it was noticed that orthopedic-knee implants were having unjustified, unreasonable and irrational high trade margins leading to their exorbitant prices.


By P.B. Jayakumar
Delhi, June 24, 2017
A number of Indian companies are facing action from the USFDA for failing manufacturing quality standards.


Mohit Malhotra
New Delhi, May 4, 2017
The recently released and long overdue National Health Policy is a welcome move for Indian citizens as the policy aims to ensure health for all by 2030.


Joe C Mathew
New Delhi, May 1, 2017
Apex think tank Niti Aayog has proposed a change in the manner the government identifies medicines that should be brought under price control.


Joe C Mathew
Delhi, May 5, 2017
The stents that Abbott and Medtronic wanted to discontinue had a price tag of Rs 1,00,000-plus.


E. Kumar Sharma
Delhi, May 1, 2017
Kiran Divi and Nilima Motaparti are under the spotlight. Indeed, all eyes are on the son and daughter of Divi's Laboratories founder Murali Divi.


Rajeev Dubey
Delhi, May 1, 2017
A group of inheritors takes charge with new ideas and new strategies


By Joe C. Mathew
Delhi, March 20, 2017
In spite of favourable court verdicts, top pharmaceutical companies are losing enthusiasm for fixed dose combination medicines.


Joe C Mathew
February 14, 2017
It fixed a ceiling price of Rs. 7,250 apiece for bare metal stents, and allowed a maximum retail price of Rs. 29,600 for drug eluting stents of all varieties. The move will be more of a shocker to the hospitals than the companies as it is common knowledge that sticker prices on the stents are multiple times higher than the price at which companies sell these products to the hospitals.


By Joe C. Mathew
Delhi, February 4, 2017
New US administration's move on H-1B visas and protectionist rhetoric are bad news for India's exports, especially from the information technology sector.


By PB Jayakumar
New Delhi, January 24, 2017
While the organised players are largely unaffected, unorganised industry hubs are facing a massive disruption in business due to demonetisation. by P.B. Jayakumar


PTI
New Delhi, January 24, 2017
The Indian Drug Manufacturers Association, a body comprising mostly home-grown pharma firms, said all excisable goods used for R&D purposes should be exempted from central excise duty.


by E Kumar Sharma
Delhi, January 21, 2017
Top pharma companies - Driven by inorganic growth opportunities - are also learning to live with more debt.


P B Jayakumar
New Delhi, January 20, 2017
The National Pharmaceutical Pricing Authority (NPPA) is seriously trying to regulate prices of stents to bring down angioplasty costs.


PAGES 5 OF 11  12345